Loading…
Reported covered position: Staff Director, Senate Veterans Affairs Committee; Legislative Director, Senator Bob Graham
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Protecting Patient Access to Cancer and Complex Therapies Act
Client: TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF PHRMA · Firm: B HALL STRATEGIES, LLC
Issues related to drug pricing. H.R.4299/S.__ - Protecting Patient Access to Cancer and Complex Therapies Act.
Protecting Patient Access to Cancer and Complex Therapies Act
Client: TIBER CREEK GROUP ON BEHALF OF TAKEDA PHARMACEUTICALS AMERICA, INC. · Firm: B HALL STRATEGIES, LLC
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
TIBER CREEK GROUP OBO ABBVIE INC. via B HALL STRATEGIES, LLC
2026 · third_quarter · Q3
Issues related to reimbursement of medications under Medicare Part B, including H.R.4299 - Protecting Patient Access to Cancer and Complex.
Filing targets: SENATE
VANTIVE US HEALTHCARE LLC via B HALL STRATEGIES, LLC
2026 · third_quarter · Q3
Source: Senate LDA
| 2025–2026 |
| TIBER CREEK GROUP ON BEHALF OF MERCK & CO., INC. | 7 | 2025–2026 |
| TIBER CREEK GROUP ON BEHALF OF MYRIAD GENETICS, INC. | 7 | 2025–2026 |
| TIBER CREEK GROUP ON BEHALF OF ORGANON, LLC | 7 | 2025–2026 |
| TIBER CREEK GROUP ON BEHALF OF PHLOW CORPORATION | 7 | 2025–2026 |
| TIBER CREEK GROUP ON BEHALF OF TAKEDA PHARMACEUTICALS AMERICA, INC. | 7 | 2025–2026 |
| TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) | 7 | 2025–2026 |
| TIBER CREEK HEALTH STRATEGIES, INC. OBO FRESENIUS MEDICAL CARE NORTH AMERICA | 7 | 2025–2026 |
| TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF AMGEN, INC. | 7 | 2025–2026 |
| TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF ELI LILLY AND COMPANY | 7 | 2025–2026 |
| TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GENENTECH, INC. | 7 | 2025–2026 |
| TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF PHRMA | 7 | 2025–2026 |
| TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GRAIL, LLC | 6 | 2025–2026 |
| TIBER CREEK GROUP OBO ABBVIE INC. | 2 | 2026 |
| TIBER CREEK GROUP OBO MUSSALLEM CHD ALLIANCE | 2 | 2026 |
| VANTIVE US HEALTHCARE LLC | 2 | 2026 |
Issues related to drug pricing. H.R.4299/S.__ - Protecting Patient Access to Cancer and Complex Therapies Act.
Protecting Patient Access to Cancer and Complex Therapies Act
Client: TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF PHRMA · Firm: B HALL STRATEGIES, LLC
Issues related to drug pricing. H.R.4299/S.__ - Protecting Patient Access to Cancer and Complex Therapies Act.
Protecting Patient Access to Cancer and Complex Therapies Act
Client: TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GENENTECH, INC. · Firm: B HALL STRATEGIES, LLC
Issues related to drug pricing. H.R.4299/S.__ - Protecting Patient Access to Cancer and Complex Therapies Act.
Protecting Patient Access to Cancer and Complex Therapies Act
Client: TIBER CREEK GROUP OBO ABBVIE INC. · Firm: B HALL STRATEGIES, LLC
Issues related to reimbursement of medications under Medicare Part B, including H.R.4299 - Protecting Patient Access to Cancer and Complex.
Protecting Patient Access to Cancer and Complex Therapies Act
Client: TIBER CREEK GROUP ON BEHALF OF DAIICHI SANKYO, INC. · Firm: B HALL STRATEGIES, LLC
Issues related to drug pricing. H.R.4299/S.__ - Protecting Patient Access to Cancer and Complex Therapies Act.
Protecting Patient Access to Cancer and Complex Therapies Act
Client: TIBER CREEK GROUP ON BEHALF OF DAIICHI SANKYO, INC. · Firm: B HALL STRATEGIES, LLC
Issues related to drug pricing. H.R.4299/S.__ - Protecting Patient Access to Cancer and Complex Therapies Act.
Protecting Patient Access to Cancer and Complex Therapies Act
Client: TIBER CREEK GROUP ON BEHALF OF TAKEDA PHARMACEUTICALS AMERICA, INC. · Firm: B HALL STRATEGIES, LLC
Issues related to drug pricing. H.R.4299/S.__ - Protecting Patient Access to Cancer and Complex Therapies Act.
Protecting Patient Access to Cancer and Complex Therapies Act
Client: TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GENENTECH, INC. · Firm: B HALL STRATEGIES, LLC
Issues related to drug pricing. H.R.4299/S.__ - Protecting Patient Access to Cancer and Complex Therapies Act.
KIDNEY Remote Monitoring Act
Client: VANTIVE US HEALTHCARE LLC · Firm: B HALL STRATEGIES, LLC
Issues related to telehealth. H.R.8319 - KIDNEY Remote Monitoring Act.
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client: TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GRAIL, LLC · Firm: B HALL STRATEGIES, LLC
Issues related to H.R.842 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act.
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client: TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GRAIL, LLC · Firm: B HALL STRATEGIES, LLC
Issues related to H.R.842 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act.
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client: TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GRAIL, LLC · Firm: B HALL STRATEGIES, LLC
Issues related to H.R. 842 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act.
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client: TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GRAIL, LLC · Firm: B HALL STRATEGIES, LLC
Issues related to H.R. 842 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act.
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Client: TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GRAIL, LLC · Firm: B HALL STRATEGIES, LLC
Issues related to H.R. 842 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act.
Issues related to telehealth. H.R.8319 - KIDNEY Remote Monitoring Act.
Filing targets: HOUSE OF REPRESENTATIVES
TIBER CREEK GROUP OBO SIEMENS HEALTHINEERS via B HALL STRATEGIES, LLC
2026 · third_quarter · Q3
Monitor issues related to device reimbursement.
TIBER CREEK GROUP ON BEHALF OF ASTELLAS PHARMA US, INC. via B HALL STRATEGIES, LLC
2026 · third_quarter · Q3
Monitor issues related to drug pricing.
TIBER CREEK GROUP ON BEHALF OF BEONE MEDICINES USA, INC. via B HALL STRATEGIES, LLC
2026 · third_quarter · Q3
Issues related to drug pricing.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF DAIICHI SANKYO, INC. via B HALL STRATEGIES, LLC
2026 · third_quarter · Q3
Issues related to drug pricing. H.R.4299/S.__ - Protecting Patient Access to Cancer and Complex Therapies Act.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF GILEAD SCIENCES, INC. via B HALL STRATEGIES, LLC
2026 · third_quarter · Q3
Issues related to drug pricing.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF JAZZ PHARMACEUTICALS via B HALL STRATEGIES, LLC
2026 · third_quarter · Q3
Issues related to drug pricing.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF MERCK & CO., INC. via B HALL STRATEGIES, LLC
2026 · third_quarter · Q3
Issues related to drug pricing.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF MYRIAD GENETICS, INC. via B HALL STRATEGIES, LLC
2026 · third_quarter · Q3
Monitor issues related to laboratory services covered under Medicare.
TIBER CREEK GROUP ON BEHALF OF ORGANON, LLC via B HALL STRATEGIES, LLC
2026 · third_quarter · Q3
Issues related to drug pricing.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF PHLOW CORPORATION via B HALL STRATEGIES, LLC
2026 · third_quarter · Q3
Issues related to domestic pharmaceutical production.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF TAKEDA PHARMACEUTICALS AMERICA, INC. via B HALL STRATEGIES, LLC
2026 · third_quarter · Q3
Issues related to drug pricing. H.R.4299/S.__ - Protecting Patient Access to Cancer and Complex Therapies Act.
Filing targets: SENATE
TIBER CREEK HEALTH STRATEGIES, INC. OBO FRESENIUS MEDICAL CARE NORTH AMERICA via B HALL STRATEGIES, LLC
2026 · third_quarter · 3T
Issues related to Medicare reimbursement.
Filing targets: SENATE
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF ELI LILLY AND COMPANY via B HALL STRATEGIES, LLC
2026 · third_quarter · Q3
Issues related to drug pricing.
Filing targets: SENATE
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GENENTECH, INC. via B HALL STRATEGIES, LLC
2026 · third_quarter · Q3
Issues related to drug pricing. H.R.4299/S.__ - Protecting Patient Access to Cancer and Complex Therapies Act.
Filing targets: SENATE
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF NOVARTIS via B HALL STRATEGIES, LLC
2026 · third_quarter · Q3
Issues related to drug pricing. Issues related to PBM reform.
Filing targets: SENATE
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF PHRMA via B HALL STRATEGIES, LLC
2026 · third_quarter · Q3
Issues related to drug pricing. H.R.4299/S.__ - Protecting Patient Access to Cancer and Complex Therapies Act.
Filing targets: SENATE
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF AMGEN, INC. via B HALL STRATEGIES, LLC
2026 · third_quarter · Q3
Issues related to drug pricing.
Filing targets: SENATE
TIBER CREEK GROUP OBO ABBVIE INC. via B HALL STRATEGIES, LLC
2026 · third_quarter · RR
Issues related to reimbursement of medications under Medicare Part B.
VANTIVE US HEALTHCARE LLC via B HALL STRATEGIES, LLC
2026 · third_quarter · RR
Issues related to telehealth.
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF PHRMA via B HALL STRATEGIES, LLC
2026 · second_quarter · Q2
Issues related to drug pricing. H.R.4299/S.__ - Protecting Patient Access to Cancer and Complex Therapies Act.
Filing targets: SENATE
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF NOVARTIS via B HALL STRATEGIES, LLC
2026 · second_quarter · Q2
Issues related to drug pricing. Issues related to PBM reform.
Filing targets: SENATE
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GRAIL, LLC via B HALL STRATEGIES, LLC
2026 · second_quarter · Q2
Issues related to H.R.842 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act.
Filing targets: SENATE
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GENENTECH, INC. via B HALL STRATEGIES, LLC
2026 · second_quarter · Q2
Issues related to drug pricing. H.R.4299/S.__ - Protecting Patient Access to Cancer and Complex Therapies Act.
Filing targets: SENATE
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF ELI LILLY AND COMPANY via B HALL STRATEGIES, LLC
2026 · second_quarter · Q2
Issues related to drug pricing.
Filing targets: SENATE
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF AMGEN, INC. via B HALL STRATEGIES, LLC
2026 · second_quarter · Q2
Issues related to drug pricing.
Filing targets: SENATE
TIBER CREEK HEALTH STRATEGIES, INC. OBO FRESENIUS MEDICAL CARE NORTH AMERICA via B HALL STRATEGIES, LLC
2026 · second_quarter · Q2
Issues related to Medicare reimbursement.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF TAKEDA PHARMACEUTICALS AMERICA, INC. via B HALL STRATEGIES, LLC
2026 · second_quarter · Q2
Issues related to drug pricing. H.R.4299/S.__ - Protecting Patient Access to Cancer and Complex Therapies Act.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF PHLOW CORPORATION via B HALL STRATEGIES, LLC
2026 · second_quarter · Q2
Issues related to domestic pharmaceutical production.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF ORGANON, LLC via B HALL STRATEGIES, LLC
2026 · second_quarter · Q2
Issues related to drug pricing.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF MYRIAD GENETICS, INC. via B HALL STRATEGIES, LLC
2026 · second_quarter · Q2
Monitor issues related to laboratory services covered under Medicare.
TIBER CREEK GROUP ON BEHALF OF MERCK & CO., INC. via B HALL STRATEGIES, LLC
2026 · second_quarter · Q2
Monitor issues related to drug pricing.
TIBER CREEK GROUP ON BEHALF OF JAZZ PHARMACEUTICALS via B HALL STRATEGIES, LLC
2026 · second_quarter · Q2
General Medicare issues impacting Jazz Pharmaceuticals.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF GILEAD SCIENCES, INC. via B HALL STRATEGIES, LLC
2026 · second_quarter · Q2
Issues related to drug pricing.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF DAIICHI SANKYO, INC. via B HALL STRATEGIES, LLC
2026 · second_quarter · Q2
Issues related to drug pricing. H.R.4299/S.__ - Protecting Patient Access to Cancer and Complex Therapies Act.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF BEONE MEDICINES USA, INC. via B HALL STRATEGIES, LLC
2026 · second_quarter · Q2
Issues related to drug pricing.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF ASTELLAS PHARMA US, INC. via B HALL STRATEGIES, LLC
2026 · second_quarter · Q2
Monitor issues related to drug pricing.
TIBER CREEK GROUP OBO SIEMENS HEALTHINEERS via B HALL STRATEGIES, LLC
2026 · second_quarter · Q2
Monitor issues related to artificial intelligence.
TIBER CREEK GROUP OBO MUSSALLEM CHD ALLIANCE via B HALL STRATEGIES, LLC
2026 · second_quarter · Q2
Activities related to Every 100th Heart.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TIBER CREEK GROUP OBO MUSSALLEM CHD ALLIANCE via B HALL STRATEGIES, LLC
2026 · second_quarter · RR
Activities related to Every 100th Heart.
TIBER CREEK GROUP OBO SIEMENS HEALTHINEERS via B HALL STRATEGIES, LLC
2026 · first_quarter · Q1
Monitor issues related to artificial intelligence.
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF AMGEN, INC. via B HALL STRATEGIES, LLC
2026 · first_quarter · Q1
Issues related to drug pricing.
Filing targets: SENATE
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF NOVARTIS via B HALL STRATEGIES, LLC
2026 · first_quarter · Q1
Issues related to drug pricing. Issues related to PBM reform.
Filing targets: SENATE
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GRAIL, LLC via B HALL STRATEGIES, LLC
2026 · first_quarter · Q1
Issues related to H.R.842 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act.
Filing targets: SENATE
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GENENTECH, INC. via B HALL STRATEGIES, LLC
2026 · first_quarter · Q1
Issues related to drug pricing.
Filing targets: SENATE
TIBER CREEK HEALTH STRATEGIES, INC. OBO FRESENIUS MEDICAL CARE NORTH AMERICA via B HALL STRATEGIES, LLC
2026 · first_quarter · Q1
Issues related to Medicare reimbursement.
Filing targets: SENATE
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF ELI LILLY AND COMPANY via B HALL STRATEGIES, LLC
2026 · first_quarter · Q1
Issues related to drug pricing.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF PHLOW CORPORATION via B HALL STRATEGIES, LLC
2026 · first_quarter · Q1
Issues related to domestic pharmaceutical production.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF ORGANON, LLC via B HALL STRATEGIES, LLC
2026 · first_quarter · Q1
Issues related to drug pricing.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF MYRIAD GENETICS, INC. via B HALL STRATEGIES, LLC
2026 · first_quarter · Q1
Monitor issues related to laboratory services covered under Medicare.
TIBER CREEK GROUP ON BEHALF OF MERCK & CO., INC. via B HALL STRATEGIES, LLC
2026 · first_quarter · Q1
Monitor issues related to drug pricing.
TIBER CREEK GROUP ON BEHALF OF TAKEDA PHARMACEUTICALS AMERICA, INC. via B HALL STRATEGIES, LLC
2026 · first_quarter · Q1
Issues related to drug pricing.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF JAZZ PHARMACEUTICALS via B HALL STRATEGIES, LLC
2026 · first_quarter · Q1
General Medicare issues impacting Jazz Pharmaceuticals.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF GILEAD SCIENCES, INC. via B HALL STRATEGIES, LLC
2026 · first_quarter · Q1
Issues related to drug pricing.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF DAIICHI SANKYO, INC. via B HALL STRATEGIES, LLC
2026 · first_quarter · Q1
Issues related to drug pricing.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF BEONE MEDICINES USA, INC. via B HALL STRATEGIES, LLC
2026 · first_quarter · Q1
Issues related to drug pricing.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF ASTELLAS PHARMA US, INC. via B HALL STRATEGIES, LLC
2026 · first_quarter · Q1
Monitor issues related to drug pricing.
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF PHRMA via B HALL STRATEGIES, LLC
2026 · first_quarter · Q1
Issues related to drug pricing.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF TAKEDA PHARMACEUTICALS AMERICA, INC. via B HALL STRATEGIES, LLC
2025 · fourth_quarter · Q4
Issues related to drug pricing.
Filing targets: SENATE
TIBER CREEK GROUP OBO SIEMENS HEALTHINEERS via B HALL STRATEGIES, LLC
2025 · fourth_quarter · Q4
Issues related to artificial intelligence.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF PHLOW CORPORATION via B HALL STRATEGIES, LLC
2025 · fourth_quarter · Q4
Issues related to domestic pharmaceutical production.
Filing targets: SENATE
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF PHRMA via B HALL STRATEGIES, LLC
2025 · fourth_quarter · Q4
Issues related to drug pricing.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF ORGANON, LLC via B HALL STRATEGIES, LLC
2025 · fourth_quarter · Q4
Issues related to drug pricing.
Filing targets: SENATE
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF NOVARTIS via B HALL STRATEGIES, LLC
2025 · fourth_quarter · Q4
Issues related to drug pricing. Issues related to PBM reform.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF MYRIAD GENETICS, INC. via B HALL STRATEGIES, LLC
2025 · fourth_quarter · Q4
Monitor issues related to laboratory services covered under Medicare.
TIBER CREEK GROUP ON BEHALF OF MERCK & CO., INC. via B HALL STRATEGIES, LLC
2025 · fourth_quarter · Q4
Monitor issues related to drug pricing.
TIBER CREEK GROUP ON BEHALF OF JAZZ PHARMACEUTICALS via B HALL STRATEGIES, LLC
2025 · fourth_quarter · Q4
General Medicare issues impacting Jazz Pharmaceuticals.
Filing targets: SENATE
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GRAIL, LLC via B HALL STRATEGIES, LLC
2025 · fourth_quarter · Q4
Issues related to H.R. 842 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF GILEAD SCIENCES, INC. via B HALL STRATEGIES, LLC
2025 · fourth_quarter · Q4
Issues related to HIV medications.
Issues related to drug pricing.
Filing targets: SENATE
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GENENTECH, INC. via B HALL STRATEGIES, LLC
2025 · fourth_quarter · Q4
Issues related to drug pricing.
Filing targets: SENATE
TIBER CREEK HEALTH STRATEGIES, INC. OBO FRESENIUS MEDICAL CARE NORTH AMERICA via B HALL STRATEGIES, LLC
2025 · fourth_quarter · Q4
Issues related to Medicare reimbursement.
Filing targets: SENATE
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF ELI LILLY AND COMPANY via B HALL STRATEGIES, LLC
2025 · fourth_quarter · Q4
Issues related to drug pricing.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF DAIICHI SANKYO, INC. via B HALL STRATEGIES, LLC
2025 · fourth_quarter · Q4
Issues related to drug pricing.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF BEONE MEDICINES USA, INC. via B HALL STRATEGIES, LLC
2025 · fourth_quarter · Q4
Issues related to drug pricing.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF ASTELLAS PHARMA US, INC. via B HALL STRATEGIES, LLC
2025 · fourth_quarter · Q4
Monitor issues related to drug pricing.
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF AMGEN, INC. via B HALL STRATEGIES, LLC
2025 · fourth_quarter · Q4
Issues related to drug pricing.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF TAKEDA PHARMACEUTICALS AMERICA, INC. via B HALL STRATEGIES, LLC
2025 · third_quarter · Q3
Issues related to drug pricing. Public Law 119-21: One Big Beautiful Bill Act.
Filing targets: SENATE
TIBER CREEK GROUP OBO SIEMENS HEALTHINEERS via B HALL STRATEGIES, LLC
2025 · third_quarter · Q3
Monitor issues related to artificial intelligence. Monitor issues related to Public Law 119-21: One Big Beautiful Bill Act.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF PHLOW CORPORATION via B HALL STRATEGIES, LLC
2025 · third_quarter · Q3
Issues related to domestic pharmaceutical production.
Issues related to domestic pharmaceutical production.
Filing targets: SENATE
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF PHRMA via B HALL STRATEGIES, LLC
2025 · third_quarter · Q3
Issues related to drug pricing. Public Law 119-21: One Big Beautiful Bill Act.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF ORGANON, LLC via B HALL STRATEGIES, LLC
2025 · third_quarter · Q3
Issues related to drug pricing. Public Law 119-21: One Big Beautiful Bill Act.
Issues related to women's health.
Issues related to women's health.
Filing targets: SENATE
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF NOVARTIS via B HALL STRATEGIES, LLC
2025 · third_quarter · Q3
Issues related to PBM reform.
Issues related to drug pricing. Monitor issues related to PBM reform. Public Law 119-21: One Big Beautiful Bill Act.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF MYRIAD GENETICS, INC. via B HALL STRATEGIES, LLC
2025 · third_quarter · Q3
Monitor issues related to laboratory services covered under Medicare.
TIBER CREEK GROUP ON BEHALF OF MERCK & CO., INC. via B HALL STRATEGIES, LLC
2025 · third_quarter · Q3
Monitor issues related to drug pricing.
TIBER CREEK GROUP ON BEHALF OF JAZZ PHARMACEUTICALS via B HALL STRATEGIES, LLC
2025 · third_quarter · Q3
Issues related to Orphan drug coverage under Medicare. General Medicare issues impacting Jazz Pharmaceuticals.
Filing targets: SENATE
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GRAIL, LLC via B HALL STRATEGIES, LLC
2025 · third_quarter · Q3
Issues related to H.R. 842 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act.
Filing targets: HOUSE OF REPRESENTATIVES
TIBER CREEK GROUP ON BEHALF OF GILEAD SCIENCES, INC. via B HALL STRATEGIES, LLC
2025 · third_quarter · Q3
Monitor issues related to HIV medications.
Issues related to drug pricing. Public Law 119-21: One Big Beautiful Bill Act.
Filing targets: SENATE
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GENENTECH, INC. via B HALL STRATEGIES, LLC
2025 · third_quarter · Q3
Issues related to drug pricing. Public Law 119-21: One Big Beautiful Bill Act.
Filing targets: SENATE
TIBER CREEK HEALTH STRATEGIES, INC. OBO FRESENIUS MEDICAL CARE NORTH AMERICA via B HALL STRATEGIES, LLC
2025 · third_quarter · Q3
Issues related to Medicare reimbursement.
Filing targets: SENATE
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF ELI LILLY AND COMPANY via B HALL STRATEGIES, LLC
2025 · third_quarter · Q3
Issues related to drug pricing. Public Law 119-21: One Big Beautiful Bill Act.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF DAIICHI SANKYO, INC. via B HALL STRATEGIES, LLC
2025 · third_quarter · Q3
Issues related to drug pricing. Public Law 119-21: One Big Beautiful Bill Act.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF BEONE MEDICINES USA, INC. via B HALL STRATEGIES, LLC
2025 · third_quarter · Q3
Monitor issues related to drug pricing. Public Law 119-21: One Big Beautiful Bill Act.
Filing targets: SENATE
TIBER CREEK GROUP ON BEHALF OF ASTELLAS PHARMA US, INC. via B HALL STRATEGIES, LLC
2025 · third_quarter · Q3
Issues related to drug pricing. Public Law 119-21: One Big Beautiful Bill Act.
Filing targets: SENATE
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF AMGEN, INC. via B HALL STRATEGIES, LLC
2025 · third_quarter · Q3
Issues related to drug pricing. Monitor Public Law 119-21: One Big Beautiful Bill Act.
Filing targets: SENATE
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GENENTECH, INC. via B HALL STRATEGIES, LLC
2025 · second_quarter · 2A
Issues related to drug pricing in the One Big Beautiful Bill Act (PL 119-21).
Filing targets: SENATE
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF PHRMA via B HALL STRATEGIES, LLC
2025 · second_quarter · Q2
Issues related to drug pricing in the One Big Beautiful Bill Act (PL 119-21).
Filing targets: SENATE
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF NOVARTIS via B HALL STRATEGIES, LLC
2025 · second_quarter · Q2
Issues related to drug pricing in the One Big Beautiful Bill Act (PL 119-21).
Issues related to PBM reform.
Filing targets: SENATE
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GRAIL, LLC via B HALL STRATEGIES, LLC
2025 · second_quarter · Q2
Issues related to H.R. 842 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act.
Filing targets: HOUSE OF REPRESENTATIVES
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF ELI LILLY AND COMPANY via B HALL STRATEGIES, LLC
2025 · second_quarter · Q2
Issues related to drug pricing in the One Big Beautiful Bill Act (PL 119-21).
Filing targets: SENATE